Impact of extremely early antiretroviral therapy to reduce VIral REservoir and induce functional CURE of HIV-1 infection. A pilot comparative study.
Phase 1
- Conditions
- HIV-1 infectionTherapeutic area: Diseases [C] - Virus Diseases [C02]
- Registration Number
- EUCTR2015-000251-24-ES
- Lead Sponsor
- Fundacio Privada Clinic per a la Recerca Biomedica
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
a. MSM (Men who have sex with men)
b. Male?s between18 and 65 years old
c. Less than 100 days of infection
d. Patient stage Fiebig I to V
e. Negative or Incomplete WB with negative p31 band
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
a. P31 positive band in WB
b. Positive Delta32 CCR5 mutation, HLA-B5701 or HLA-B27 (´late? exclusion criteria)
c. Active oncological disease
d. Active HCV infection
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method